[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"invasive-breast-cancer-early-stages\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:invasive-breast-cancer-early-stages":23},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":24,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100315774","long-term-follow-up-study-of-early-stage-breast-cancer-patients-included-in-geicam-studies-100315774",false,"NCT03390894","Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies","Inclusion Criteria:\n\n* Patients included in neoadjuvant and adjuvant clinical trials with GEICAM's participation. If any of these patients had taken part or is participating in another clinical trial, she\u002Fhe is eligible for this trial and her\u002Fhis information will also be collected.\n* Patients whose death or contact loss has not been previously collected in the databases of the original studies.\n\nExclusion Criteria:\n\n* Patient who were not included in the analyses of the original studies due to non-compliance of the eligibility criteria or the original study informed consent withdrawal.","FEMALE","18 Years",{"count":18,"type":19},8000,"ESTIMATED","OBSERVATIONAL","This is a multicenter, cohorts study to collect information from patients diagnosed with early-stage invasive breast cancer who have been previously included in a neoadjuvant or adjuvant clinical trial of the GEICAM group.\n\nPatients will be included in this study from the moment of completion of the follow-up of the studies of origin and will be followed for approximately 30 years",[23],"Invasive Breast Cancer Early Stages",[25,23,26,27],"Long-term Follow-Up","Previous Neoadjuvant treatment","Previous Adjuvant treatment","RECRUITING","2025-05-13",{"date":31,"type":32},"2025-05-14","ACTUAL",{"date":34,"type":32},"2018-01-18",{"date":36,"type":19},"2048-01",{"name":38,"class":39},"Spanish Breast Cancer Research Group","OTHER",73]